The company aims to start a pivotal trial this year, file for 510(k) clearance in 2027 and launch the device in 2028.

Fashion brands talk of inclusivity, but runway castings are again ‘zeroing’ on skinny models with ultra-thin frames, sharp ...

US-based Sequel Med Tech has introduced its Tidepool-powered twiist automated insulin delivery (AID) system across the ...

As demand grows for reliable positioning beyond conventional Global Navigation Satellite Systems (GNSS), researchers are turning to Low Earth Orbit ...

Latent Health is tapping into the $200 billion market for specialty drugs with AI agents that help doctors convince insurers ...

AI Is in the Room, But Who Owns the Decision? In more and more leadership meetings, AI is quietly becoming the “fifth person ...

CamDiab announced today that it is introducing CamAPS Liberty, a fully closed-loop feature for its CamAPS FX app.

An autonomous platform uses machine learning and patterned light to detect and terminate cardiac arrhythmias in real time ...

Monday, March 16 th at 1:30 PM PT, Viva Biotech (01873.HK) optimizes the Proteina-Complexa model in advancing the design of ...

With nationwide availability now underway, twiist reaches a meaningful milestone in Sequel’s mission to empower the diabetes ...

Brands that run headfirst into AI-driven processes may be accidentally automating away their most valuable asset: credibility ...

Insulet Presents Promising Study Results for Fully Closed-Loop Automated Insulin Delivery System for Adults with Type 2 ...